Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights urn:uuid:2266f432-003c-e457-13a0-3da78a8083fa 2026-06-18T14:51:24-04:00 Jonathan Moreland Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services SNDX: BOTWOOD NICHOLAS A J (SO) Exercised 53,750 Options (OE) of SYNDAX PHARMACEUTICALS INC for $13.82 on 6/11-6/12, and Sold Them All urn:uuid:405347f7-1a2a-800d-7e8f-8fff42718215 2026-06-12T17:09:52-04:00 SNDX: GOLDAN KEITH A (CFO) Sold (S) 1,177 Shares of SYNDAX PHARMACEUTICALS INC for $18.99 on 6/1 urn:uuid:bd4ed9f2-65a9-523b-e9c2-d7086b50b200 2026-06-02T16:30:06-04:00 SNDX: METZGER MICHAEL A (CEO,DIR) Sold (S) 6,847 Shares of SYNDAX PHARMACEUTICALS INC for $18.99 on 6/1 urn:uuid:0bae6c0d-930b-c57c-563a-309e4215d03a 2026-06-02T16:30:02-04:00 SNDX: METZGER MICHAEL A (CEO,DIR) Sold (S) 17,159 Shares of SYNDAX PHARMACEUTICALS INC for $21.03 on 2/9 urn:uuid:f75d3d81-428f-3cd0-9e57-a6e6a93e0d8e 2026-02-10T09:00:18-05:00 SNDX: GOLDAN KEITH A (CFO) Sold (S) 3,410 Shares of SYNDAX PHARMACEUTICALS INC for $21.03 on 2/9 urn:uuid:3d05e936-563c-94b0-d374-9b7b60ad8044 2026-02-10T08:59:55-05:00 SNDX: METZGER MICHAEL A (CEO,DIR) Acquired (JB) 217,600 Shares of SYNDAX PHARMACEUTICALS INC for $0.00 on 2/4 urn:uuid:fddacdac-db1f-5a4f-8287-99cb7d5844d0 2026-02-06T17:54:06-05:00 SNDX: METZGER MICHAEL A (CEO,DIR) Sold (S) 7,412 Shares of SYNDAX PHARMACEUTICALS INC for $20.62 on 2/6 urn:uuid:b45f1af6-d2e4-799f-d269-4bc839ba1bcb 2026-02-06T17:54:06-05:00 SNDX: GOLDAN KEITH A (CFO) Acquired (JB) 53,469 Shares of SYNDAX PHARMACEUTICALS INC for $8.48 on 1/30-2/4 urn:uuid:7117b94d-8d56-c127-c98d-e14534bf0b06 2026-02-06T17:53:43-05:00 SNDX: GOLDAN KEITH A (CFO) Sold (S) 2,082 Shares of SYNDAX PHARMACEUTICALS INC for $20.62 on 2/6 urn:uuid:488be681-5b1b-f133-3322-24dde4d5ad9f 2026-02-06T17:53:43-05:00